MDS clinical diagnostic criteria for Parkinson's disease

By R. Postuma, D. Berg, M. Stern, W. Poewe, C. Olanow, W. Oertel, Jose A. Obeso, K. Marek, I. Litvan, A. Lang and 8 more. Movement Disorders, 2015

6,818 citations recorded by the source corpus.

Subfields: Neurology

View Paper: https://www.semanticscholar.org/paper/4be7f3e8f8142247599eba69bacd9630bcb66a88

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

Citations in the corpus

Past, Present, and Future of Parkinson’s Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy (2017, neutral): “However, the major problem in the differential diagnosis of atypical parkinsonism with PD remains the well-recognized fact that a large number of patients with atypical parkinsonism will not present with these hallmark features early or ever during the course of the disease.(17) This phenotypic vari”
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature (2021, methodology): “Therefore, non-motor symptoms do not yet allow for diagnosis of PD independently (Braak et al., 2003), although some have been used as supportive diagnostic criteria (Postuma et al., 2015).”
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. (2020, methodology): “Inclusion criteria: age 50–85 years with clinically probable Parkinson’s disease according to Movement Disorder Society (MDS) criteria (Postuma et al., 2015).”
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy (2022, background): “Bradykinesia associated with rigidity or tremor (excluding intentional tremor in a patient with cerebellar syndrome), ascertained by a movement disorder specialist, defines parkinsonism in MSA.(33) A beneficial response to levodopa in 42.”
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction (2023, background): “Non-motor symptoms such as hyposmia, urinary and gastrointestinal dysfunctions in PD patients have stimulated the search for α-syn-related biomarkers in peripheral sites and tissues implicated in these dysfunctions [120].”
Diagnosis and management of dementia with Lewy bodies (2017, background): “Parkinsonism in Parkinson disease (PD) is defined as bradykinesia in combination with rest tremor, rigidity, or both.(18) Many DLB patients’ parkinsonism falls short of this, so documentation of only one of these cardinal features is required.”
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study (2019, methodology): “(iii) Quantitative motor testing: tests included the alternate-tap test (Nutt et al., 2000; Postuma et al., 2015c), Purdue PegBoard (Desrosiers et al., 1995; Postuma et al., 2015c), 3-Metre Timed-Up-and-Go (Podsiadlo and Richardson, 1991; Postuma et al., 2015c), or Flamingo balance test (Barber et…”